Alibaba participated in the cancer diagnostic kit provider’s first funding round in over a year, pushing its overall funding past $230m.
Month: October 2021
Deal making growth continues in September
Monthly data: September 2021
Culture Biosciences cultivates $80m in funding
The biomanufacturing technology provider received more backing from Alphabet subsidiary Verily in its series B round and has now raised over $100m to date.
Corporate venturing’s momentum continues in Q3
Quarterly data: Q3 2021
Lively delivers $80m series C round
The Ally Ventures-backed HAS platform operator’s latest round included Telstra Ventures and took its total funding to in excess of $120m.
Beacon Platform attracts investors to $56m round
Global Atlantic returned for another bite at the capital markets software provider, in a series C round which will help it scale its product.
Brazil empowers innovation
Innovative region: Brazil
SumUp buys FiveStars for $317m
SumUp is purchasing the Rogers Communications-backed payment and marketing software provider to bolster its trans-Atlantic presence.
Aware sees $60m in funding through
The employee monitoring platform developer will use the proceeds from the Goldman Sachs-led series C round to grow its business.
The green gambit – investing for corporate strategic advantage in the post-covid-19 world
Comment by Alan Martinovich, partner, head of the North American strategy and organisation practice, Arthur D Little
Oil and gas venturing in the third quarter of 2021
Sector report: Oil and gas
GCVI Summit 2021 review
For many of the attendees at the Global Corporate Venturing and Innovation Summit 2021 held late last month in Monterey, California, the conference was their first in-real life (IRL) event since the pandemic effectively stopped them in the first quarter last year after the previous summit.
From entrepreneurs to studios to agents
October 2021 issue editorial by James Mawson, editor-in-chief, Global Corporate Venturing
Daily Deal Round Up: October 18, 2021
Corporate-backed communications monetisation technology developer Matrixx Software raised $50m from Francisco Partners while cancer drug developer Abalos took the same in a BIVF-backed round.